ReviewExpert opinion on therapeutic targets2021
Targeting translesion synthesis (TLS) to expose replication gaps, a unique cancer vulnerability.
Sumeet Nayak et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this papercites it